Bioceltix is a biotechnology company that develops modern medicinal products for companion animals, with particular emphasis on dogs and horses. The company develops a proprietary technology for the production of biological drugs based on mesenchymal stem cells. The breakthrough of the Bioceltix approach lies in the use of a method that allows the administration of stem cells from a small number of healthy donors to a large number of patients, i.e. in an allogeneic model.
We use cookies to improve your browsing experience, display ads and content, and analyze traffic on our sites. By clicking “Accept all,” you consent to our use of cookies.
